| Name | Title | Contact Details |
|---|
Mactus Group is a Redmond, WA-based company in the Computers and Electronics sector.
Acclaim Technology, Inc. is a San Jose, CA-based company in the Computers and Electronics sector.
The HRS Group is a global tech company with a focus on business travel. HRS is one of the market leaders in the global business travel market, and in Europe one of the top three hotel portals. As an outsourcing provider for global corporations, the company simplifies the processes related to hotel stays and offers travel managers and the travelers themselves forward-looking solutions. Multinational corporations, business travelers and hotel partners benefit equally from the global network of the HRS Group. Founded in Cologne in 1972, the steadily expanding group of companies employs more than 1,500 people in more than 35 offices worldwide including Shanghai, Tokyo, Singapore, Paris, London, Warsaw, Mumbai, São Paulo, New York and Sydney. As a result, the HRS Group combines a global network with local market expertise.
CVP is an award-winning healthcare and next-gen technology and consulting services firm that helps organizations achieve lasting transformation and build a healthy, safe, and equitable world. A future that is better for themselves, their employees, their customers, and their communities. We call that future What`s Next.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.